Solway Pharmaceuticals Private Limited
About Solway Pharmaceuticals Private Limited
Data last updated:
Solway Pharmaceuticals Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239HR2016PTC065450. Its GSTIN is 06AAXCS5322H1Z0 (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rakesh Jakhar and Mohit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 77 Sector – B Defence Colony, Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.16 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹1.18 Lakh (net margin -3.5%) and EBITDA of -₹99,453 (EBITDA margin -2.9%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address77 Sector – B Defence Colony, Ambala Cantt, Haryana, India – 133001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Solway Pharmaceuticals Private Limited
The main business activity of Solway Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Solway Pharmaceuticals Private Limited FY 2025 filings available
Solway Pharmaceuticals Private Limited reported revenue of ₹34.16 Lakh (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Solway Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 11% fall in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Solway Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹99,453 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.18 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Solway Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Solway Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Solway Pharmaceuticals Private Limited
Solway Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Jakhar | Director | 17 Aug 2016 | 10 Years 2 Months | Current |
| Mohit Kumar | Director | 17 Aug 2016 | 10 Years 2 Months | Current |
| Mukesh Rani | Director | 08 Jan 2018 | 8 Years 9 Months | Current |
Peer Comparison of Solway Pharmaceuticals Private Limited
Solway Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ulisses Pharmaceuticals Private Limited | ₹34.2 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | New Delhi, Delhi, India |
| Craicean Pharmaceuticals Private Limited | ₹34.19 Lakh (FY 2024) | •••• | •••• | 8.0% | •••• | Lucknow, Uttar Pradesh, India |
| Indigrammy Pharmaceuticals Private Limited | ₹34.18 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Thane, Maharashtra, India |
| Dew Lifecare Private Limited | ₹34.18 Lakh (FY 2024) | •••• | •••• | 18.0% | •••• | Vadodara, Gujarat, India |
| Concent Biotech Private Limited | ₹34.18 Lakh (FY 2018) | •••• | •••• | -42.0% | •••• | Lucknow, Uttar Pradesh, India |
| Solway Pharmaceuticals Private Limited this company | ₹34.16 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Ambala Cantt, Haryana, India |
| Etios Pharmaceuticals Private Limited | ₹34.15 Lakh (FY 2024) | •••• | •••• | -12.0% | •••• | Ranchi, Jharkhand, India |
| Shakambhari Pharmaceuticals Private Limited | ₹34.14 Lakh (FY 2024) | •••• | •••• | •••• | Aurangabad, Maharashtra, India | |
| Frokeen Pharmaceuticals Private Limited | ₹34.12 Lakh (FY 2025) | •••• | •••• | 119.0% | •••• | Ahmedabad, Gujarat, India |
| Glide Pharmaceuticals Private Limited | ₹34.08 Lakh (FY 2025) | •••• | •••• | 148.0% | •••• | Palashbari Circle, Assam, India |
| Manobal Healthcare Private Limited | ₹34.06 Lakh (FY 2020) | •••• | •••• | -14.0% | •••• | Naigoan, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Solway Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Solway Pharmaceuticals Private Limited
Solway Pharmaceuticals Private Limited is audited by AJAY MITTAL & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AJAY MITTAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Solway Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Solway Pharmaceuticals Private Limited
Solway Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Solway Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Solway Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Solway Pharmaceuticals Private Limited
Solway Pharmaceuticals Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Mukesh Rani was appointed as Director on 08 Jan 2018.
Credit Ratings, Litigation & Regulatory Alerts for Solway Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Solway Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Solway Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Solway Pharmaceuticals Private Limited
Solway Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAXCS5322H1Z0 | Haryana | Active | 20 Aug 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Solway Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Solway Pharmaceuticals Private Limited
Solway Pharmaceuticals is an active private limited company based in Ambala Cantt, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 August 2016 (10+ years old) and is registered under CIN U24239HR2016PTC065450.
Solway Pharmaceuticals reported revenue of ₹34.16 Lakh for FY 2025 (down 11% YoY).
Solway Pharmaceuticals has 3 current directors:
- Rakesh Jakhar - Director
- Mohit Kumar - Director
- Mukesh Rani - Director
Solway Pharmaceuticals reported a net loss of ₹1.18 Lakh (net margin -3.5%) and EBITDA of -₹99,453 (EBITDA margin -2.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Solway Pharmaceuticals is -18% over three years and -7% over five years. In the latest year (FY 2025) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Solway Pharmaceuticals is 06AAXCS5322H1Z0, registered in Haryana.
The CIN (Corporate Identification Number) of Solway Pharmaceuticals is U24239HR2016PTC065450. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solway Pharmaceuticals was incorporated on 17 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Solway Pharmaceuticals by revenue are Ulisses Pharmaceuticals Private Limited, Craicean Pharmaceuticals Private Limited, Indigrammy Pharmaceuticals Private Limited, Dew Lifecare Private Limited, Concent Biotech Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Mukesh Rani was appointed as Director on 08 Jan 2018. Mohit Kumar was appointed as Director on 17 Aug 2016. Rakesh Jakhar was appointed as Director on 17 Aug 2016.
The registered office of Solway Pharmaceuticals is at 77 Sector – B Defence Colony, Ambala Cantt, Haryana, India – 133001.